Accelerate insights with multimodal RWD in a changing regulatory environment

Join us for an important look at how leading pharma companies are leveraging RWD to answer important questions of viability, safety, and efficacy, ultimately achieving greater clarity in research and drug development.

Experts will discuss:

  • How to achieve greater efficiency with multimodal data across a variety of use cases
  • Why securely and compliantly linked RWD is necessary to understand the full patient journey
  • How recent policy changes like the Inflation Reduction Act are poised to affect pharma and what you can do about it
  • Ways data and analytics will change clinical development for the benefit of patients 

Request Free!